Last reviewed · How we verify
Processingdeficient progeroid laminopathies
Approved treatments
- Zokinvy · Sentynl Theraps Inc
Lonafarnib prevents farnesylation of progerin and similar proteins by inhibiting farnesyltransferase.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Processingdeficient progeroid laminopathies patent landscape — cliff calendar, originator estates, attackable patents
- Processingdeficient progeroid laminopathies treatment landscape brief
- Processingdeficient progeroid laminopathies treatment updates RSS
Frequently asked questions about Processingdeficient progeroid laminopathies
What drugs treat Processingdeficient progeroid laminopathies?
Tracked treatments include Zokinvy.
What is the treatment for Processingdeficient progeroid laminopathies?
Standard treatment for Processingdeficient progeroid laminopathies includes Zokinvy. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Processingdeficient progeroid laminopathies patent cliff · Processingdeficient progeroid laminopathies CI report
- Treatment: Zokinvy · Sentynl Theraps Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing